 |
Articles: Drug Approvals |
ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Companys TAP Technology
ImmunoGen, Inc., 11/20/09
Free full text
Prior Articles
Human genome sciences receives complete response letter from fda for raxibacumab biologics license application
Human Genome Sciences, 11/17/09
Free full text
Panenza, Sanofi Pasteurs Influenza A(H1N1) 2009 Vaccine, Approved in France
Sanofi-aventis, 11/17/09
Free full text
Par pharmaceutical receives final approval to market generic ultram er
Par Pharmaceutical, 11/17/09 Novartis receives approval in Switzerland for Celtura, a cell culture-based Influenza A(H1N1) pandemic vaccine
Novartis, 11/16/09
Free full text
Covidien Introduces First FDA-Approved Spine Sealant
Covidien, 11/13/09 Pandemic 2009 Influenza Update: US FDA approves GSKs pandemic H1N1 vaccine
GlaxoSmithKline, 11/12/09
Free full text
Teva Receives Final Approval For Generic Prevacid Delayed-Release Capsules
Teva Pharmaceutical Industries, 11/11/09
Free full text
Mylan Receives FDA Approval for Generic Version of Prevacid Through its Subsidiary Matrix Laboratories
Mylan, 11/11/09 Anti-Malignancy Agent Avastin: Obtained Approval for Additional Indication of Non-Small Cell Lung Cancer
Chugai Pharmaceutical Co., 11/10/09
Free full text
United States Patent Office Issues Patent Covering the Approved Administration of Kuvan With Food
BioMarin, 11/06/09
Free full text
Covidien Receives FDA Approval for Oral Transmucosal Fentanyl Citrate Product
Covidien, 11/05/09 ViiV Healthcare launches: A new specialist HIV company dedicated to delivering advances in HIV treatment and care
GlaxoSmithKline, 11/04/09
Free full text
Retigabine Regulatory Update
GlaxoSmithKline, 11/03/09
Free full text
Gilead Sciences Announces Plans for Phase IV Clinical Trial Evaluating First-Line Combination Therapy Versus Monotherapy in Pulmonary Arterial Hypertension
Gilead, 11/03/09
Free full text
Dendreon Completes Submission of Biologics License Application for PROVENGE
Dendreon Coproration, 11/03/09
Free full text
Morphine/naltrexone extended-release capsules (Embeda): Combination of mu-opioid agonist and mu-opioid antagonist approved for the management of moderate-to-severe pain when continuous analgesia is needed for an extended time period
Formulary, 11/02/09
Free full text
Fampridine-SR: A potassium-channel blocker for the improvement of walking ability in patients with MS
Formulary, 11/02/09
Free full text
BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
Amylin Pharmaceuticals, 11/02/09
Free full text
FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Gen-Probe, 11/02/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
166 Available Pages
|
|
